Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 52, Issue SUPPL1, 2013, Pages 148-154

  Liu, Li ^a,b,c   An, Jiaze ^d   Liu, Jibin ^c   Wen, Juan ^a   Zhai, Xiangjun ^e   Liu, Yao ^a   Pan, Shandong ^a   Jiang, Jie ^a   Wen, Yang ^a   Liu, Zheng ^f   Zhang, Yixin ^c   Chen, Jianguo ^g   Xing, Jinliang ^h   Ji, Guozhong ^f   Shen, Hongbing ^a   Hu, Zhibin ^a   Fan, Zhining ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANTONG TUMOR HOSPITAL   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^g Qidong Liver Cancer Research Institute   (China)

^h FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DICER1; HCC; MiRNA; PIWIL1; RAN; SNP

Indexed keywords

DICER; MICRORNA; RAN PROTEIN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; REPORTER GENE; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

DICER1; HCC; MIRNA; PIWIL1; RAN; SNP;

3' UNTRANSLATED REGIONS; ARGONAUTE PROTEINS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RAN GTP-BINDING PROTEIN; RIBONUCLEASE III; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 84886292273     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22062     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-538.
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355.
5. Chowdhury TT, Salter DM, Bader DL, Lee DA. Integrin-mediated mechanotransduction processes in TGFbeta-stimulated monolayer-expanded chondrocytes. Biochem Biophys Res Commun 2004; 318:873-881.
6. Gregory RI, Yan KP, Amuthan G, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432:235-240.
7. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004; 10:185-191.
8. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436:740-744.
9. Esquela-Kerscher A, Slack FJ. Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
10. Kitagawa N, Ojima H, Shirakihara T, et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013; 104:543-551.
11. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39:673-677.
12. Faggad A, Budczies J, Tchernitsa O, et al. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol 2010; 220:382-391.
13. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010; 31:1805-1812.
14. Horikawa Y, Wood CG, Yang H, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008; 14:7956-7962.
15. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 2008; 68:2530-2537.
16. Thu KL, Chari R, Lockwood WW, Lam S, Lam WL. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J Thorac Oncol 2011; 6:1594-1598.
17. Ma H, Yuan H, Yuan Z, et al. Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population. PLoS ONE 2012; 7:e47544.
18. Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer: A systematic review. Eur Urol 2011; 59:671-681.
19. Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 2011; 17:4277-4284.
20. Ma Q, Yang L, Wang C, Yu YY, Zhou B, Zhou ZG. Differential expression of colon cancer microRNA in microarray study. Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42:344-348.
21. Dahiya N, Sherman-Baust CA, Wang TL, et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008; 3:e2436.
22. Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131:1109-1123.
23. Wu JF, Shen W, Liu NZ, et al. Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol 2011; 28:804-809.
24. Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012; 106:768-774.
25. Gui J, Tian Y, Wen X, et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011; 120:183-193.
26. Lund E, Güttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303:95-98.
27. Shatseva T, Lee DY, Deng Z, Yang BB. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 2011; 124:2826-2836.
28. Chen R, Alvero AB, Silasi DA, et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008; 27:4712-4723.
29. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25:2537-2545.
30. Ichimi T, Enokida H, Okuno Y, et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009; 125:345-352.
31. Kang AD, Wong PM, Chen H, et al. Restoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein. Infect Immun 1996; 64:4612-4617.
32. Lingel A, Sattler M. Novel modes of protein-RNA recognition in the RNAi pathway. Curr Opin Struct Biol 2005; 15:107-115.
33. Liu WK, Jiang XY, Zhang ZX. Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma. Onkologie 2010; 33:241-245.
34. Liu WK, Jiang XY, Zhang ZX. Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. Arch Virol 2010; 155:657-663.
35. Li L, Yu C, Gao H, Li Y. Argonaute proteins: Potential biomarkers for human colon cancer. BMC Cancer 2010; 10:38.
36. Jiang J, Zhang H, Tang Q, Hao B, Shi R. Expression of HIWI in human hepatocellular carcinoma. Cell Biochem Biophys 2011; 61:53-58.